CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,420 | -99.9% | 1,441,735 | +9.3% | 0.01% | 0.0% |
| Q3 2022 | $8,841,000 | +69.0% | 1,319,508 | +6.2% | 0.01% | +66.7% |
| Q2 2022 | $5,231,000 | +24.6% | 1,242,576 | -0.2% | 0.00% | +50.0% |
| Q1 2022 | $4,197,000 | -1.2% | 1,245,412 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $4,250,000 | +15.3% | 1,349,229 | +19.7% | 0.00% | 0.0% |
| Q3 2021 | $3,687,000 | -31.8% | 1,127,630 | -12.0% | 0.00% | -33.3% |
| Q2 2021 | $5,407,000 | +7.6% | 1,281,267 | +27.2% | 0.00% | -25.0% |
| Q1 2021 | $5,026,000 | -55.3% | 1,007,240 | +13.1% | 0.00% | -50.0% |
| Q4 2020 | $11,253,000 | +10.0% | 890,253 | -14.6% | 0.01% | -38.5% |
| Q3 2020 | $10,231,000 | -15.7% | 1,041,883 | -14.6% | 0.01% | -23.5% |
| Q2 2020 | $12,136,000 | +23.6% | 1,219,738 | +9.8% | 0.02% | -22.7% |
| Q1 2020 | $9,821,000 | +165.1% | 1,110,940 | +176.6% | 0.02% | +340.0% |
| Q4 2019 | $3,705,000 | +71.1% | 401,630 | +9.0% | 0.01% | +66.7% |
| Q3 2019 | $2,165,000 | -65.6% | 368,325 | -29.8% | 0.00% | -66.7% |
| Q2 2019 | $6,295,000 | -43.3% | 524,564 | -43.0% | 0.01% | -47.1% |
| Q1 2019 | $11,105,000 | -12.5% | 920,068 | -9.1% | 0.02% | -15.0% |
| Q4 2018 | $12,698,000 | +58.3% | 1,011,753 | +87.2% | 0.02% | +100.0% |
| Q3 2018 | $8,020,000 | -27.7% | 540,441 | -18.0% | 0.01% | -28.6% |
| Q2 2018 | $11,094,000 | +12.2% | 659,152 | +52.6% | 0.01% | +7.7% |
| Q1 2018 | $9,890,000 | -47.3% | 431,883 | -40.5% | 0.01% | -50.0% |
| Q4 2017 | $18,779,000 | +471.3% | 725,885 | +225.8% | 0.03% | +420.0% |
| Q3 2017 | $3,287,000 | +26.6% | 222,819 | +19.7% | 0.01% | 0.0% |
| Q2 2017 | $2,597,000 | -18.5% | 186,168 | -0.3% | 0.01% | -16.7% |
| Q1 2017 | $3,187,000 | +33.0% | 186,800 | -19.8% | 0.01% | +20.0% |
| Q4 2016 | $2,396,000 | +102.7% | 232,896 | +99.1% | 0.01% | +150.0% |
| Q3 2016 | $1,182,000 | -63.0% | 116,962 | -58.9% | 0.00% | -71.4% |
| Q2 2016 | $3,194,000 | -58.8% | 284,421 | -49.9% | 0.01% | -63.2% |
| Q1 2016 | $7,757,000 | -55.3% | 567,868 | -38.0% | 0.02% | -48.6% |
| Q4 2015 | $17,369,000 | -4.7% | 915,625 | -5.7% | 0.04% | +5.7% |
| Q3 2015 | $18,226,000 | +116.7% | 971,019 | +71.9% | 0.04% | +118.8% |
| Q2 2015 | $8,410,000 | +49.4% | 564,810 | +51.9% | 0.02% | +60.0% |
| Q1 2015 | $5,631,000 | +74.6% | 371,822 | +53.6% | 0.01% | +42.9% |
| Q4 2014 | $3,225,000 | +1443.1% | 242,080 | +1070.8% | 0.01% | +600.0% |
| Q2 2014 | $209,000 | +1.5% | 20,676 | +35.3% | 0.00% | 0.0% |
| Q1 2014 | $206,000 | – | 15,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |